| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $8,303,833 ) |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01AI152119 | Urine tenofovir point-of-care test to identify patients in need of ART adherence support | 001 | 4 | NIH | 7/6/2023 | $181,647 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R21TW012384 | Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke | 001 | 1 | NIH | 8/16/2023 | -$165,924 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | UM1AI069521 | Stellenbosch University Clinical Trials Unit | 000 | 17 | NIH | 12/12/2022 | $609,217 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R21TW012384 | Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke | 001 | 1 | NIH | 8/16/2023 | $165,924 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01AI175235 | Identifying correlates of risk for future tuberculosis disease progression in children (INTREPID) | 000 | 1 | NIH | 5/5/2023 | $590,947 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | U01AI152075 | Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb) | 000 | 3 | NIH | 1/31/2023 | $1,500,000 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01AI175235 | Identifying correlates of risk for future tuberculosis disease progression in children (INTREPID) | 000 | 1 | NIH | 5/5/2023 | $250,000 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01AI152109 | Nanoparticle-based host-directed therapies for eradication of Mycobacterium tuberculosis | 000 | 4 | NIH | 3/27/2023 | $192,405 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW012591 | Development of a Next-generation Rapid Phenotypic Assay for Drug-Resistant M. tuberculosis | 000 | 1 | NIH | 7/12/2023 | $105,893 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW012577 | A comprehensive whole genome sequence scan for positive selection in southern Africa | 000 | 1 | NIH | 7/21/2023 | $90,196 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01AI152109 | Nanoparticle-based host-directed therapies for eradication of Mycobacterium tuberculosis | 000 | 4 | NIH | 3/27/2023 | $125,820 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW012577 | A comprehensive whole genome sequence scan for positive selection in southern Africa | 001 | 1 | NIH | 8/4/2023 | $7,207 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW012577 | A comprehensive whole genome sequence scan for positive selection in southern Africa | 002 | 1 | NIH | 8/10/2023 | -$97,402 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01HD102050 | MECHANISMS LEADING TO ADVERSE BIRTH OUTCOMES IN SOUTH AFRICAN HIV-INFECTED WOMEN | 000 | 4 | NIH | 3/17/2023 | $184,836 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01HD102050 | MECHANISMS LEADING TO ADVERSE BIRTH OUTCOMES IN SOUTH AFRICAN HIV-INFECTED WOMEN | 000 | 4 | NIH | 3/17/2023 | $130,908 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW012577 | A comprehensive whole genome sequence scan for positive selection in southern Africa | 002 | 1 | NIH | 8/10/2023 | $97,403 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R21TW012358 | Altered mitochondrial function and HIV-associatedcardiometabolic disease in populations from South Africa and Kenya (MITO-SAKen) | 001 | 2 | NIH | 6/26/2023 | $154,156 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW011006 | Interdisciplinary and multi-level approach to estimate the disease burden and outcomes of childhood tuberculous meningitis. | 000 | 4 | NIH | 1/11/2023 | $113,400 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01AI136894 | Pre- and post-treatment lung microbiota, metabolome and immune signatures at the site of disease in patients with active pulmonary tuberculosis | 000 | 5 | NIH | 6/5/2023 | $128,047 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01MH131480 | The changing face of HIV in the era of COVID-19: Maximising HIV incidence reduction through dynamic targeting of current and future distributions of acquisition risk. | 000 | 1 | NIH | 2/16/2023 | $517,216 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01HD107063 | Understanding ischemia in children with tuberculous meningitis (iThemba) | 000 | 2 | NIH | 6/1/2023 | $448,500 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01AI136837 | Adaptation, fitness and resistance in rifampicin-resistant M. tuberculosis | 000 | 4 | NIH | 5/23/2023 | $136,947 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW012302 | Longitudinal microbiome-host interactions and clinical outcomes in drug-resistant tuberculosis patients | 000 | 2 | NIH | 6/12/2023 | $89,253 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | D43TW010547 | Africa Center for Biostatistical Excellence: Expanding biostatistical leadership for HIV/AIDS and TB Research | 002 | 7 | NIH | 4/21/2023 | $249,412 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | D71TW012265 | Next generation training in HIV research: Immunity in the First 1000 days in mother-infant dyads (TIGRIS) | 000 | 2 | NIH | 1/20/2023 | $30,240 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | D43TW010547 | Africa Center for Biostatistical Excellence: Expanding biostatistical leadership for HIV/AIDS and TB Research | 002 | 7 | NIH | 4/21/2023 | $50,000 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | U01MH127704 | Research for Ethical Data Science in Southern Africa (REDSSA) | 000 | 3 | NIH | 8/1/2023 | $393,983 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R33HD103093 | CHERISH (Children HIV Exposed Uninfected Research to Inform Survival and Health) | 000 | 3 | NIH | 8/17/2023 | $519,496 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW011028 | The long-term consequences of pulmonary tuberculosis and respiratory viruses on lung health in young South African children | 000 | 4 | NIH | 7/12/2023 | $113,362 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01MH133488 | Harnessing male peer networks to enhance engagement with HIV prevention: A large-scale cluster randomized trial to increase HIV self-testing and PrEP uptake among men in Eastern Zimbabwe | 000 | 1 | NIH | 8/3/2023 | $500,029 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01AI152119 | Urine tenofovir point-of-care test to identify patients in need of ART adherence support | 001 | 4 | NIH | 7/6/2023 | $150,250 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R21TW012384 | Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke | 000 | 1 | NIH | 8/14/2023 | $165,925 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | UM1AI069521 | Stellenbosch University Clinical Trials Unit | 001 | 17 | NIH | 6/23/2023 | $342,524 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | UM1AI069521 | Stellenbosch University Clinical Trials Unit | 001 | 17 | NIH | 6/23/2023 | $266,692 |
| | 2023 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01AI152119 | Urine tenofovir point-of-care test to identify patients in need of ART adherence support | 000 | 3 | NIH | 4/21/2023 | $0 |
| | 2023 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R21TW012358 | Altered mitochondrial function and HIV-associatedcardiometabolic disease in populations from South Africa and Kenya (MITO-SAKen) | 000 | 1 | NIH | 3/20/2023 | $0 |
| | 2023 | 2022 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | D43TW010547 | Africa Center for Biostatistical Excellence: Expanding biostatistical leadership for HIV/AIDS and TB Research | 001 | 6 | NIH | 4/4/2023 | $267,087 |
| | 2023 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01AI152119 | Urine tenofovir point-of-care test to identify patients in need of ART adherence support | 000 | 3 | NIH | 4/21/2023 | $0 |
| | 2023 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | D43TW010511 | Advancing Research Ethics Training in Southern Africa (ARESA): Leadership Program | 000 | 5 | NIH | 4/1/2023 | $0 |
| | 2023 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R61HD103093 | CHERISH (Children HIV Exposed Uninfected Research to Inform Survival and Health) | 000 | 2 | NIH | 3/2/2023 | $0 |
| | 2023 | 2021 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | D43TW010547 | Africa Center for Biostatistical Excellence: Expanding biostatistical leadership for HIV/AIDS and TB Research | 000 | 5 | NIH | 4/4/2023 | -$267,087 |
| | 2023 | 2020 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | K43TW010682 | Developing a care bundle for neonatal sepsis prevention in low-resource settings | 000 | 4 | NIH | 3/15/2023 | -$13,020 |
| | 2023 | 2019 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | U01CA200441 | Characterizing HIV-1 diversity, evolution, and integration sites in children initiating cART in early infection | 000 | 5 | NIH | 10/17/2022 | -$21,681 |
| | 2023 | 2019 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R01AI116039 | Altered immune-endocrine axis in type 2 diabetes and tuberculosis risk | 000 | 5 | NIH | 12/6/2022 | $0 |
| | 2023 | 2019 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | U01CA200441 | Characterizing HIV-1 diversity, evolution, and integration sites in children initiating cART in early infection | 001 | 5 | NIH | 5/17/2023 | $25 |
|
| Issue Date FY: 2022 ( Subtotal = $4,772,275 ) (Continued on the next page) |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW011028 | The long-term consequences of pulmonary tuberculosis and respiratory viruses on lung health in young South African children | 000 | 3 | NIH | 7/18/2022 | $113,345 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | U01MH127704 | Research for Ethical Data Science in Southern Africa (REDSSA) | 001 | 2 | NIH | 8/12/2022 | $400,000 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW011006 | Interdisciplinary and multi-level approach to estimate the disease burden and outcomes of childhood tuberculous meningitis. | 000 | 3 | NIH | 1/10/2022 | $109,032 |
|
